Overview

Acute Treatment of Bipolar II Depression

Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
0
Participant gender:
All
Summary
This study will compare the medications lithium and lamotrigine (Lamictal®) in treating depression in individuals with bipolar II disorder.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Stanford University
Collaborator:
National Institute of Mental Health (NIMH)
Treatments:
Anticonvulsants
Lamotrigine
Lithium Carbonate
Criteria
Inclusion Criteria:

- Current diagnosis of bipolar II disorder

Exclusion Criteria:

- Use of lithium or lamotrigine

- Intolerance to lithium or lamotrigine

- Substance abuse or dependence within the last month

- Suicidal thoughts

- Unstable medical conditions

- Pregnancy or breast-feeding

- Stable on current medications

- Use of fluoxetine (Prozac) within 2 weeks of study

- Require an antipsychotic medication

- Do not speak or read English